Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01472692 · ClinicalTrials.gov registry record · Phase 4
Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure
A Phase 4 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 4
- Development phase
- 47
- Enrollment target
NCT01472692 is a Phase 4 study that has completed, run by University of California, San Diego. The registered enrollment target is 47 participants.
The verdict
NCT01472692, a Phase 4 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 47 participants
- Enrollment target
Study Summary
High normal blood pressure, also called prehypertension, is a significant problem. High uric acid in the blood, the same thing that causes gout, may cause higher blood pressures. The investigators plan to monitor the effects of the drug febuxostat(trade name Uloric) on blood pressure and stiffness of the main blood vessels and see if lowering uric acid has any effect.
Interventions
- DRUG Febuxostat
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2011-10 |
| Est. Completion | 2014-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01472692
The ClinicalTrials.gov registry entry for NCT01472692 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Febuxostat is the first listed.
NCT01472692 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01472692 about?
NCT01472692 is a clinical study titled "Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure". High normal blood pressure, also called prehypertension, is a significant problem. High uric acid in the blood, the same thing that causes gout, may cause higher blood pressures. The investigators plan to monitor the effects of the drug febuxostat(trade name Uloric) on blood pressure and stiffness o...
What is the current status of trial NCT01472692?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 47 participants. The study started on 2011-10. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01472692?
The interventions under investigation include: Febuxostat (DRUG).
Who is sponsoring clinical trial NCT01472692?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.